Chemotherapy of Leishmaniasis: Past, Present and Future
A special issue of Tropical Medicine and Infectious Disease (ISSN 2414-6366). This special issue belongs to the section "Vector-Borne Diseases".
Deadline for manuscript submissions: 31 May 2024 | Viewed by 201
Special Issue Editors
Interests: leishmaniasis; Leishmania sp.; chemotherapy; treatment failure; drug resistance; drug discovery
Interests: leishmaniasis; toxoplasmosis; drug discovery; drug screening; pre-clinical assays
Special Issue Information
Dear Colleagues,
Leishmaniasis is a neglected disease caused by protozoa of the genus Leishmania, which may manifest differently depending on the Leishmania species and the immune response of the human host. Only a limited number of chemotherapeutic agents are available for treating this neglected infectious disease, most of which require parenteral administration and may cause serious side effects. The search for new drugs to treat this disease is imperative.
For this Special Issue, we hope to receive original research articles and reviews that focus on current and potential new drugs for leishmaniasis chemotherapy. Additionally, this Special Issue may offer new insights into understanding the mechanisms of action and resistance of current and alternative drugs proposed for the treatment of this parasitic disease.
Dr. Adriano Cappellazzo Coelho
Dr. Juliana Quero Reimão
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Tropical Medicine and Infectious Disease is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- chemotherapy
- leishmaniasis
- leishmania species
- drug discovery
- drug resistance
